Displaying 9 (all) recruiting clinical trials.
-
Prospective Databased of Clinical Outcomes Following Cryotherapy for ablation of clinically localized prostate cancer
The purpose of this study is to better understand how well Cryo Ablation treats prostate cancer and the long-term effects of this treatment of sexual ... -
NYU Winthrop Hospital Minimally Invasive Treatment for BPH Database
The rationale and specific goal of this research is to build a database of patients undergoing the Urolift or Rezum procedure for benign prostatic hyperplasia ... -
NYU Cooperative Prostate Cancer Tissue Resource
The purpose of this study is to collect prostate tissue, blood, urine, and health information from a large group of patients for whom prostate cancer ... -
Comparing UroLift Experience Against Rezum (C.L.E.A.R. Study)
The purpose of this study is to compare two different minimally invasive procedures often used to treat the symptoms of benign prostatic hyperplasia (BPH): the ... -
INTREPId (INTermediate Risk Erection PreservatIon Trial): A Randomized Trial of Radiation Therapy and Darolutamide for Prostate Cancer
The purpose of the trial is to determine whether Darolutamide plus radiation therapy (RT) is non-inferior to gonadotropin releasing hormone (GnRH) agonist and bicalutamide plus ... -
A PHASE 1/2 STUDY OF REGN5678 (ANTI-PSMAXCD28) WITH CEMIPLIMAB (ANTI-PD-1) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER [Regeneron 5678-ONC-1879]
The purpose of the trial is to determine safety and tolerability of REGN5678 alone and in combination with cemiplimab in treatment-experienced metastatic castration-resistant prostate cancer ... -
Anabolic Androgenic Steroid Use among Gay Bisexual and Queer Men in NYC
The purpose of this research study is to understand the experiences of gay, bisexual, and queer (GBQ) men who use anabolic androgenic steroids (AAS), also ... -
A Phase 1 and 2a trial of LAVA-1207 in patients with therapy refractory metastatic castration resistant prostate cancer
The purpose of the study is to determine and investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary antitumor activity of LAVA-1207, a bi-specific antibody ... -
A Phase I Open-label Multi-center Clinical Study to Evaluate Safety Tolerability Pharmacokinetics Pharmacodynamics and Preliminary Anti-Tumor Activity of AC176 in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) Who Have Progressed on at Least Two Prior Systemic Therapies
This study is designed for patients diagnosed with metastatic castration resistant prostate cancer (mCRPC).
This is a Phase I, first-in-human, open-label, multi-center dose-escalation study of ...